Kristen Evans
Adult Health · Overland, MONPI 1972972073
Payments from drug & device makers
Across 171 payments — averaging $15.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$425
- Novo Nordisk$357
- AbbVie$302
- GSK$260
- AstraZeneca$252
- Takeda Pharmaceuticals U.S.A., Inc.$183
- plus $873 from 21 others
What the payments were for
- Food & beverage$2,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 27 | $425 |
| Novo Nordisk | 24 | $357 |
| AbbVie | 14 | $302 |
| GSK | 26 | $260 |
| AstraZeneca | 14 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $183 |
| Boehringer Ingelheim | 10 | $166 |
| Lilly USA, LLC | 9 | $150 |
| Biohaven Pharmaceuticals, Inc. | 5 | $73 |
| Merck | 4 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $54 |
| Amarin Pharma, Inc. | 3 | $41 |
| Dexcom, Inc. | 3 | $41 |
| Johnson & Johnson | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Abbott | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Gilead | 1 | $16 |
| Bayer | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$119
How this compares
$2,653 in reported general payments places this provider in the 80th percentile of 555 adult health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $62,243 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $43,311 |
| EliquisApixaban | 42 | $37,735 |
| FarxigaDapagliflozin Propanediol | 32 | $25,597 |
| TrulicityDulaglutide | 13 | $21,419 |
| JardianceEmpagliflozin | 15 | $17,946 |
| JanuviaSitagliptin Phosphate | 12 | $17,693 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 47 | $10,466 |
| LinzessLinaclotide | 13 | $9,075 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,530 |
| MyrbetriqMirabegron | 15 | $7,081 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 17 | $6,348 |
| Atorvastatin Calcium | 439 | $2,863 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,289 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $1,875 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $357 | $62,24346 claims |
| GSKTrelegy Ellipta, Shingrix | $260 | $53,77796 claims |
| PfizerEliquis | $425 | $37,73542 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $252 | $33,12844 claims |
| Lilly USA, LLCTrulicity | $150 | $21,41913 claims |
| Boehringer IngelheimJardiance | $166 | $17,94615 claims |
| MerckJanuvia | $61 | $17,69312 claims |
| AbbVieLinzess | $302 | $9,07513 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $7,08115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 555 adult health providers in Missouri.
Other adult health in Overland
- Tabitha StithChesterfield$300K
- Stephanie VogelSaint Louis$115K
- Racquel FrisellaChesterfield$110K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
- Katie MurrayIndependence$59K
- Patrick BehnkeChesterfield$54K
- Elaine ZobristFenton$38K
- Yolanda Thompson MartinKansas City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.